Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival.

Wang LW, Wang Z, Ersing I, Nobre L, Guo R, Jiang S, Trudeau S, Zhao B, Weekes MP, Gewurz BE.

PLoS Pathog. 2019 Sep 13;15(9):e1008030. doi: 10.1371/journal.ppat.1008030. [Epub ahead of print]

2.

CRISPR/Cas9 Screens Reveal Multiple Layers of B cell CD40 Regulation.

Jiang C, Trudeau SJ, Cheong TC, Guo R, Teng M, Wang LW, Wang Z, Pighi C, Gautier-Courteille C, Ma Y, Jiang S, Wang C, Zhao B, Paillard L, Doench JG, Chiarle R, Gewurz BE.

Cell Rep. 2019 Jul 30;28(5):1307-1322.e8. doi: 10.1016/j.celrep.2019.06.079.

3.

Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation.

Wang LW, Shen H, Nobre L, Ersing I, Paulo JA, Trudeau S, Wang Z, Smith NA, Ma Y, Reinstadler B, Nomburg J, Sommermann T, Cahir-McFarland E, Gygi SP, Mootha VK, Weekes MP, Gewurz BE.

Cell Metab. 2019 Sep 3;30(3):539-555.e11. doi: 10.1016/j.cmet.2019.06.003. Epub 2019 Jun 27.

4.

TAF Family Proteins and MEF2C Are Essential for Epstein-Barr Virus Super-Enhancer Activity.

Wang C, Jiang S, Zhang L, Li D, Liang J, Narita Y, Hou I, Zhong Q, Gewurz BE, Teng M, Zhao B.

J Virol. 2019 Jul 30;93(16). pii: e00513-19. doi: 10.1128/JVI.00513-19. Print 2019 Aug 15.

PMID:
31167905
5.

Genome-wide CRISPR-based gene knockout screens reveal cellular factors and pathways essential for nasopharyngeal carcinoma.

Wang C, Jiang S, Ke L, Zhang L, Li D, Liang J, Narita Y, Hou I, Chen CH, Wang L, Zhong Q, Ling Y, Lv X, Xiang Y, Guo X, Teng M, Tsao SW, Gewurz BE, Zeng MS, Zhao B.

J Biol Chem. 2019 Jun 21;294(25):9734-9745. doi: 10.1074/jbc.RA119.008793. Epub 2019 May 9.

PMID:
31073033
6.

RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes.

Wang C, Li D, Zhang L, Jiang S, Liang J, Narita Y, Hou I, Zhong Q, Zheng Z, Xiao H, Gewurz BE, Teng M, Zhao B.

J Virol. 2019 Jun 14;93(13). pii: e00226-19. doi: 10.1128/JVI.00226-19. Print 2019 Jul 1.

PMID:
31019051
7.

Epigenetic crossroads of the Epstein-Barr virus B-cell relationship.

Frost TC, Gewurz BE.

Curr Opin Virol. 2018 Oct;32:15-23. doi: 10.1016/j.coviro.2018.08.012. Epub 2018 Sep 15. Review.

PMID:
30227386
8.

Author Correction: Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry.

Zhang H, Li Y, Wang HB, Zhang A, Chen ML, Fang ZX, Dong XD, Li SB, Du Y, Xiong D, He JY, Li MZ, Liu YM, Zhou AJ, Zhong Q, Zeng YX, Kieff E, Zhang Z, Gewurz BE, Zhao B, Zeng MS.

Nat Microbiol. 2018 Sep;3(9):1075. doi: 10.1038/s41564-018-0155-1.

PMID:
29679064
9.

Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300.

Wang C, Zhou H, Xue Y, Liang J, Narita Y, Gerdt C, Zheng AY, Jiang R, Trudeau S, Peng CW, Gewurz BE, Zhao B.

J Virol. 2018 Apr 13;92(9). pii: e02155-17. doi: 10.1128/JVI.02155-17. Print 2018 May 1.

10.

CRISPR-Cas9 Genetic Analysis of Virus-Host Interactions.

Gebre M, Nomburg JL, Gewurz BE.

Viruses. 2018 Jan 30;10(2). pii: E55. doi: 10.3390/v10020055. Review.

11.

CRISPR/Cas9-Mediated Genome Editing in Epstein-Barr Virus-Transformed Lymphoblastoid B-Cell Lines.

Jiang S, Wang LW, Walsh MJ, Trudeau SJ, Gerdt C, Zhao B, Gewurz BE.

Curr Protoc Mol Biol. 2018 Jan 16;121:31.12.1-31.12.23. doi: 10.1002/cpmb.51.

PMID:
29337376
12.

Modulating Gene Expression in Epstein-Barr Virus (EBV)-Positive B Cell Lines with CRISPRa and CRISPRi.

Wang LW, Trudeau SJ, Wang C, Gerdt C, Jiang S, Zhao B, Gewurz BE.

Curr Protoc Mol Biol. 2018 Jan 16;121:31.13.1-31.13.18. doi: 10.1002/cpmb.50.

13.

Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry.

Zhang H, Li Y, Wang HB, Zhang A, Chen ML, Fang ZX, Dong XD, Li SB, Du Y, Xiong D, He JY, Li MZ, Liu YM, Zhou AJ, Zhong Q, Zeng YX, Kieff E, Zhang Z, Gewurz BE, Zhao B, Zeng MS.

Nat Microbiol. 2018 Feb;3(2):1-8. doi: 10.1038/s41564-017-0080-8. Epub 2018 Jan 1. Erratum in: Nat Microbiol. 2018 Apr 20;:.

PMID:
29292383
14.

Epstein-Barr Virus LMP1-Mediated Oncogenicity.

Wang LW, Jiang S, Gewurz BE.

J Virol. 2017 Oct 13;91(21). pii: e01718-16. doi: 10.1128/JVI.01718-16. Print 2017 Nov 1. Review.

15.

A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells.

Ersing I, Nobre L, Wang LW, Soday L, Ma Y, Paulo JA, Narita Y, Ashbaugh CW, Jiang C, Grayson NE, Kieff E, Gygi SP, Weekes MP, Gewurz BE.

Cell Rep. 2017 May 16;19(7):1479-1493. doi: 10.1016/j.celrep.2017.04.062.

16.

CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors.

Ma Y, Walsh MJ, Bernhardt K, Ashbaugh CW, Trudeau SJ, Ashbaugh IY, Jiang S, Jiang C, Zhao B, Root DE, Doench JG, Gewurz BE.

Cell Host Microbe. 2017 May 10;21(5):580-591.e7. doi: 10.1016/j.chom.2017.04.005.

17.

Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease.

Minamitani T, Ma Y, Zhou H, Kida H, Tsai CY, Obana M, Okuzaki D, Fujio Y, Kumanogoh A, Zhao B, Kikutani H, Kieff E, Gewurz BE, Yasui T.

Proc Natl Acad Sci U S A. 2017 May 2;114(18):4751-4756. doi: 10.1073/pnas.1701836114. Epub 2017 Mar 28.

18.

CRISPR/Cas9 Screens Reveal Requirements for Host Cell Sulfation and Fucosylation in Bacterial Type III Secretion System-Mediated Cytotoxicity.

Blondel CJ, Park JS, Hubbard TP, Pacheco AR, Kuehl CJ, Walsh MJ, Davis BM, Gewurz BE, Doench JG, Waldor MK.

Cell Host Microbe. 2016 Aug 10;20(2):226-37. doi: 10.1016/j.chom.2016.06.010. Epub 2016 Jul 21.

19.

The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma.

Hunter JE, Butterworth JA, Zhao B, Sellier H, Campbell KJ, Thomas HD, Bacon CM, Cockell SJ, Gewurz BE, Perkins ND.

Oncogene. 2016 Jun 30;35(26):3476-84. doi: 10.1038/onc.2015.399. Epub 2015 Nov 2.

20.

Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2A.

Minamitani T, Yasui T, Ma Y, Zhou H, Okuzaki D, Tsai CY, Sakakibara S, Gewurz BE, Kieff E, Kikutani H.

Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11612-7. doi: 10.1073/pnas.1514484112. Epub 2015 Aug 24.

21.

TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.

Greenfeld H, Takasaki K, Walsh MJ, Ersing I, Bernhardt K, Ma Y, Fu B, Ashbaugh CW, Cabo J, Mollo SB, Zhou H, Li S, Gewurz BE.

PLoS Pathog. 2015 May 21;11(5):e1004890. doi: 10.1371/journal.ppat.1004890. eCollection 2015 May.

22.

Epstein-Barr virus oncoprotein super-enhancers control B cell growth.

Zhou H, Schmidt SC, Jiang S, Willox B, Bernhardt K, Liang J, Johannsen EC, Kharchenko P, Gewurz BE, Kieff E, Zhao B.

Cell Host Microbe. 2015 Feb 11;17(2):205-16. doi: 10.1016/j.chom.2014.12.013. Epub 2015 Jan 29.

23.

Regulation of p53 and Rb links the alternative NF-κB pathway to EZH2 expression and cell senescence.

Iannetti A, Ledoux AC, Tudhope SJ, Sellier H, Zhao B, Mowla S, Moore A, Hummerich H, Gewurz BE, Cockell SJ, Jat PS, Willmore E, Perkins ND.

PLoS Genet. 2014 Sep 25;10(9):e1004642. doi: 10.1371/journal.pgen.1004642. eCollection 2014 Sep.

24.

The NF-κB genomic landscape in lymphoblastoid B cells.

Zhao B, Barrera LA, Ersing I, Willox B, Schmidt SC, Greenfeld H, Zhou H, Mollo SB, Shi TT, Takasaki K, Jiang S, Cahir-McFarland E, Kellis M, Bulyk ML, Kieff E, Gewurz BE.

Cell Rep. 2014 Sep 11;8(5):1595-606. doi: 10.1016/j.celrep.2014.07.037. Epub 2014 Aug 21.

25.

Remodeling of the intestinal brush border underlies adhesion and virulence of an enteric pathogen.

Zhou X, Massol RH, Nakamura F, Chen X, Gewurz BE, Davis BM, Lencer WI, Waldor MK.

MBio. 2014 Aug 19;5(4). pii: e01639-14. doi: 10.1128/mBio.01639-14.

26.

NF-κB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1.

Ersing I, Bernhardt K, Gewurz BE.

Viruses. 2013 Jun 21;5(6):1587-606. doi: 10.3390/v5061587. Review.

27.

A Vibrio parahaemolyticus T3SS effector mediates pathogenesis by independently enabling intestinal colonization and inhibiting TAK1 activation.

Zhou X, Gewurz BE, Ritchie JM, Takasaki K, Greenfeld H, Kieff E, Davis BM, Waldor MK.

Cell Rep. 2013 May 30;3(5):1690-702. doi: 10.1016/j.celrep.2013.03.039. Epub 2013 Apr 25.

28.

Genome-wide siRNA screen for mediators of NF-κB activation.

Gewurz BE, Towfic F, Mar JC, Shinners NP, Takasaki K, Zhao B, Cahir-McFarland ED, Quackenbush J, Xavier RJ, Kieff E.

Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2467-72. doi: 10.1073/pnas.1120542109. Epub 2012 Jan 17.

29.

Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation.

Gewurz BE, Mar JC, Padi M, Zhao B, Shinners NP, Takasaki K, Bedoya E, Zou JY, Cahir-McFarland E, Quackenbush J, Kieff E.

J Virol. 2011 Jul;85(13):6764-73. doi: 10.1128/JVI.00422-11. Epub 2011 May 4.

30.

Herpesvirus evasion of T-cell immunity.

Gewurz BE, Vyas JM, Ploegh HL.

In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 62.

31.

Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines.

Zhao B, Mar JC, Maruo S, Lee S, Gewurz BE, Johannsen E, Holton K, Rubio R, Takada K, Quackenbush J, Kieff E.

Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):337-42. doi: 10.1073/pnas.1017419108. Epub 2010 Dec 20.

32.

Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.

Boehm D, Gewurz BE, Kieff E, Cahir-McFarland E.

Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18103-8. doi: 10.1073/pnas.1011752107. Epub 2010 Oct 5.

33.

IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3.

Song YJ, Izumi KM, Shinners NP, Gewurz BE, Kieff E.

Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18448-53. doi: 10.1073/pnas.0809933105. Epub 2008 Nov 18.

34.

Human herpesvirus 6 encephalitis.

Gewurz BE, Marty FM, Baden LR, Katz JT.

Curr Infect Dis Rep. 2008 Jul;10(4):292-9.

PMID:
18765102
35.

Human babesiosis.

Vannier E, Gewurz BE, Krause PJ.

Infect Dis Clin North Am. 2008 Sep;22(3):469-88, viii-ix. doi: 10.1016/j.idc.2008.03.010. Review.

36.

Persistent and relapsing babesiosis in immunocompromised patients.

Krause PJ, Gewurz BE, Hill D, Marty FM, Vannier E, Foppa IM, Furman RR, Neuhaus E, Skowron G, Gupta S, McCalla C, Pesanti EL, Young M, Heiman D, Hsue G, Gelfand JA, Wormser GP, Dickason J, Bia FJ, Hartman B, Telford SR 3rd, Christianson D, Dardick K, Coleman M, Girotto JE, Spielman A.

Clin Infect Dis. 2008 Feb 1;46(3):370-6. doi: 10.1086/525852.

PMID:
18181735
37.

DNA-damage control: Claspin destruction turns off the checkpoint.

Gewurz BE, Harper JW.

Curr Biol. 2006 Nov 7;16(21):R932-4.

38.

HIV and the breast.

Gewurz BE, Dezube BJ, Pantanowitz L.

AIDS Read. 2005 Aug;15(8):392-6, 399-402. Review.

PMID:
16110554
39.

Capravirine, a nonnucleoside reverse-transcriptase inhibitor in patients infected with HIV-1: a phase 1 study.

Gewurz BE, Jacobs M, Proper JA, Dahl TA, Fujiwara T, Dezube BJ.

J Infect Dis. 2004 Dec 1;190(11):1957-61. Epub 2004 Oct 27.

PMID:
15529260
40.

US2, a human cytomegalovirus-encoded type I membrane protein, contains a non-cleavable amino-terminal signal peptide.

Gewurz BE, Ploegh HL, Tortorella D.

J Biol Chem. 2002 Mar 29;277(13):11306-13. Epub 2002 Jan 14.

41.

Virus subversion of immunity: a structural perspective.

Gewurz BE, Gaudet R, Tortorella D, Wang EW, Ploegh HL.

Curr Opin Immunol. 2001 Aug;13(4):442-50. Review.

PMID:
11498300
42.

Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2.

Gewurz BE, Gaudet R, Tortorella D, Wang EW, Ploegh HL, Wiley DC.

Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6794-9.

43.
44.

Either B7 costimulation or IL-2 can elicit generation of primary alloreactive CTL.

McAdam AJ, Gewurz BE, Farkash EA, Sharpe AH.

J Immunol. 2000 Sep 15;165(6):3088-93.

45.

Viral subversion of the immune system.

Tortorella D, Gewurz BE, Furman MH, Schust DJ, Ploegh HL.

Annu Rev Immunol. 2000;18:861-926. Review.

PMID:
10837078
47.

Phenotypic switching of Haemophilus influenzae.

Moxon ER, Gewurz BE, Richards JC, Inzana T, Jennings MP, Hood DW.

Mol Microbiol. 1996 Mar;19(5):1149-50. No abstract available.

PMID:
8830271
48.

Reactivity of anti-human C-reactive protein (CRP) and serum amyloid P component (SAP) monoclonal antibodies with limulin and pentraxins of other species.

Ying SC, Marchalonis JJ, Gewurz AT, Siegel JN, Jiang H, Gewurz BE, Gewurz H.

Immunology. 1992 Jun;76(2):324-30.

49.

Localization of sequence-determined neoepitopes and neutrophil digestion fragments of C-reactive protein utilizing monoclonal antibodies and synthetic peptides.

Ying SC, Shephard E, de Beer FC, Siegel JN, Harris D, Gewurz BE, Fridkin M, Gewurz H.

Mol Immunol. 1992 May;29(5):677-87.

PMID:
1374844

Supplemental Content

Loading ...
Support Center